Skip to main content
Skip to main menu
OnkPat consists of more than 30 research groups
Research groups A-Ö
Our associate professors
Core facilities and common equipment
CCK Friday Seminar
Review in Nature Reviews Cancer
Klas Wiman and co-workers have published a review article in Nature Reviews Cancer. The article discusses recent progress in pharmacological reactivation of p53 and highlights problems and promises with these strategies.
Study of protein expression in mouse ovarian follicles
Associate Professor Kenny Rodriguez-Wallberg and Amandine Anastacio, post doc at the department of Oncology-Pathology, together with researchers in France have published an article in Molecular Human Reproduction. The study maps protein expression during different developmental stages of ovarian follicles in mice.
New top publication from OnkPat regarding breast cancer
Johan Hartman and co-workers have recently published their work on the most aggressive breast cancer cells, cancer stem cells, in Journal of the National Cancer Institute. They have found that cancer stem cells are dependent on a certain estrogen receptor to survive. This receptor could therefore be used as a new target for breast cancer treatment.
Review in Seminars in Cancer Biology
Researchers at OnkPat together with Italian researchers review recent studies on the acidic tumor environment and how this affects tumor growth and therapeutic efficacy.
Two junior researchers at OnkPat receives funding for their positions from the Swedish Cancer Society
Christofer Juhlin and Nathaniel Vacanti receives funding for six and three years respectively from the Swedish Cancer Society.
Findings suggesting a new treatment strategy for leukemia
Researchers at OnkPat has contributed to a publication in Nature Medicine where they identify a protein important for the effect of cytarabin - the backbone in the treatment of acute myeloic leukemia.
OnkPat researcher receives funding from SSMF
Christofer Juhlin is one of eight young researchers who receives funding from Swedish Society for Medical Research (SSMF)
Tailored, Dense-Dose Chemotherapy for Early Breast Cancer Does Not Result in Significant Improvement in Recurrence-Free Survival
A group of researchers led by Jonas Bergh present the results of a study on micrometastatic disease in the internationally recognized publication JAMA.
24 Apr 2018 by